Condition: Cataract Surgery · Cataract and Fuchs Endothelial Corneal Dystrophy · Sponsor: University of Cologne
The purpose of the study is to investigate whether there is a difference in BCVA in patients who receive one of the following two surgeries: intervention group (arm 1) cataract surgery alone and control group (arm 2) cataract surgery combined with removal of the diseased endothelial cells and the attached Descemet's membrane followed by transplantation of a healthy endothelial cell layer with attached Descemet's membrane ("triple-DMEK" group; comparator therapy). The secondary objectives are to compare the two surgical methods with regard to other visual functions and optical as well as morphological differences, to safety, to quality of life, and to safety.
This description comes directly from the study's public registry record.
Björn Bachmann, Prof. · 0049-221 478-87476 · bjoern.bachmann@uk-koeln.de
Always discuss trial participation with your own doctor first.
| Department of Ophthalmology, Aarhus University Hospital | Aarhus N, Central Jutland, Denmark | Not Yet Recruiting |
| Klinik für Ophthalmologie des Universitätsklinikums Köln | Cologne, North Rhine-Westphalia, Germany | Recruiting |
| Radboud-Universität Nijmegen | Nijmegen, Gelderland, Netherlands | Not Yet Recruiting |
| Instituto de microcirugía ocular; Departamento de Cornea y Cirugia Refractiva | Barcelona, Barcelona, Spain | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06425666